Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
Lienhardt C, Vernon AA, Cavaleri M, Nambiar S, Nahid P
PLoS medicine · 2019-09
Abstract
Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.
MeSH terms
- Humans
- Tuberculosis
- Antitubercular Agents
- Treatment Outcome
- Endpoint Determination
- Drug Approval
- Public Health
- Research Design
- Policy Making
- Clinical Trials as Topic
- Biomarkers